Westermark, P., Andersson, A
reported a 48-week randomized trial in adults with obesity but without diabetes
Telehealth-based services will continue to dominate weight loss care, with an emphasis on remote monitoring, personalized medical adjustments, and at-home medication delivery systems such as weight loss shots at home
Liraglutide, in combination with metformin, has demonstrated synergistic antipancreatic cancer effects in both in vivo and in vitro studies [8]
To assess safety, we performed next-generation sequencing to evaluate the on-target site and the top 10 potential off-target sites in liver genomic DNA from in vivo knock-in mice
The 4 mg maintenance dose produced 17.1% average weight loss across the full trial population, but lighter individuals within that group often experienced responses closer to 20% or higher